Literature DB >> 21839424

Risk factors for illicit anabolic-androgenic steroid use in male weightlifters: a cross-sectional cohort study.

Harrison G Pope1, Gen Kanayama, James I Hudson.   

Abstract

BACKGROUND: Illicit anabolic-androgenic steroid (AAS) abuse, though an important public health problem, remains inadequately studied. Almost all AAS abusers are male and lift weights, but the risk factors for AAS use among male weightlifters remain poorly understood.
METHODS: We recruited 233 experienced male weightlifters, of whom 102 (44%) reported lifetime AAS use, and assessed their childhood and adolescent attributes retrospectively, using structured clinical interviews and computerized questionnaires. This cross-sectional cohort approach-a design that we have formally presented in the recent methodological literature-utilizes a study cohort, not selected for outcomes of interest, and assesses exposures and outcomes retrospectively. We hypothesized that conduct disorder and body-image concerns would be major risk factors for subsequent AAS use among male weightlifters.
RESULTS: Within our study population, many attributes showed little association with AAS use, but conduct disorder and body-image concerns showed strong associations. For individuals with prior conduct disorder versus those without, the hazard ratio (95% confidence interval) for subsequent AAS use was 2.2 (1.5, 3.4). For individuals in the middle versus lowest tertile of scores on a retrospective adolescent muscle-dysmorphia scale, the hazard ratio was 1.5 (.84, 2.6); for the highest versus lowest tertile, the hazard ratio was 3.3 (2.0, 5.3); and for the linear trend of hazard ratios, p < .001.
CONCLUSIONS: Conduct disorder and body-image concerns represent important risk factors for AAS use among male weightlifters. Thus, assessment of these attributes may help to identify individuals most likely to require interventions to discourage this form of substance abuse.
Copyright © 2012 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21839424      PMCID: PMC3218214          DOI: 10.1016/j.biopsych.2011.06.024

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  44 in total

1.  Prevalence of and risk factors for lifetime suicide attempts in the National Comorbidity Survey.

Authors:  R C Kessler; G Borges; E E Walters
Journal:  Arch Gen Psychiatry       Date:  1999-07

2.  Neuropsychological performance in long-term cannabis users.

Authors:  H G Pope; A J Gruber; J I Hudson; M A Huestis; D Yurgelun-Todd
Journal:  Arch Gen Psychiatry       Date:  2001-10

3.  Neurobehavioral disinhibition in childhood predicts early age at onset of substance use disorder.

Authors:  Ralph E Tarter; Levent Kirisci; Ada Mezzich; Jack R Cornelius; Kathleen Pajer; Michael Vanyukov; William Gardner; Timothy Blackson; Duncan Clark
Journal:  Am J Psychiatry       Date:  2003-06       Impact factor: 18.112

4.  Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Wai Tat Chiu; Olga Demler; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

5.  Trends in non-medical use of anabolic steroids by U.S. college students: results from four national surveys.

Authors:  Sean Esteban McCabe; Kirk J Brower; Brady T West; Toben F Nelson; Henry Wechsler
Journal:  Drug Alcohol Depend       Date:  2007-05-23       Impact factor: 4.492

6.  Early-onset drug use and risk of later drug problems.

Authors:  J C Anthony; K R Petronis
Journal:  Drug Alcohol Depend       Date:  1995-11       Impact factor: 4.492

7.  Analysis of anabolic steroids in hair by GC/MS/MS.

Authors:  C Gambelunghe; M Sommavilla; C Ferranti; R Rossi; K Aroni; N Manes; M Bacci
Journal:  Biomed Chromatogr       Date:  2007-04       Impact factor: 1.902

8.  The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder.

Authors:  M F Ward; P H Wender; F W Reimherr
Journal:  Am J Psychiatry       Date:  1993-06       Impact factor: 18.112

Review 9.  Illicit anabolic-androgenic steroid use.

Authors:  Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Horm Behav       Date:  2009-09-18       Impact factor: 3.587

Review 10.  Anabolic steroid use: patterns of use and detection of doping.

Authors:  Michael R Graham; Bruce Davies; Fergal M Grace; Andrew Kicman; Julien S Baker
Journal:  Sports Med       Date:  2008       Impact factor: 11.136

View more
  27 in total

1.  National Athletic Trainers' Association position statement: anabolic-androgenic steroids.

Authors:  Robert D Kersey; Diane L Elliot; Linn Goldberg; Gen Kanayama; James E Leone; Mike Pavlovich; Harrison G Pope
Journal:  J Athl Train       Date:  2012 Sep-Oct       Impact factor: 2.860

2.  The lifetime prevalence of anabolic-androgenic steroid use and dependence in Americans: current best estimates.

Authors:  Harrison G Pope; Gen Kanayama; Alison Athey; Erin Ryan; James I Hudson; Aaron Baggish
Journal:  Am J Addict       Date:  2013-09-20

Review 3.  Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement.

Authors:  Harrison G Pope; Ruth I Wood; Alan Rogol; Fred Nyberg; Larry Bowers; Shalender Bhasin
Journal:  Endocr Rev       Date:  2013-12-17       Impact factor: 19.871

Review 4.  Eating Disorders in Males.

Authors:  Sasha Gorrell; Stuart B Murray
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2019-07-11

5.  Cardiovascular Toxicity of Illicit Anabolic-Androgenic Steroid Use.

Authors:  Aaron L Baggish; Rory B Weiner; Gen Kanayama; James I Hudson; Michael T Lu; Udo Hoffmann; Harrison G Pope
Journal:  Circulation       Date:  2017-05-23       Impact factor: 29.690

Review 6.  Anabolic androgenic steroid abuse in the United Kingdom: An update.

Authors:  Carrie Mullen; Benjamin J Whalley; Fabrizio Schifano; Julien S Baker
Journal:  Br J Pharmacol       Date:  2020-03-03       Impact factor: 8.739

Review 7.  Androgenic anabolic steroid exposure during adolescence: ramifications for brain development and behavior.

Authors:  Rebecca L Cunningham; Augustus R Lumia; Marilyn Y McGinnis
Journal:  Horm Behav       Date:  2012-12-26       Impact factor: 3.587

8.  Cognitive deficits in long-term anabolic-androgenic steroid users.

Authors:  Gen Kanayama; Joseph Kean; James I Hudson; Harrison G Pope
Journal:  Drug Alcohol Depend       Date:  2012-12-14       Impact factor: 4.492

Review 9.  Nephrotoxic effects of common and emerging drugs of abuse.

Authors:  William F Pendergraft; Leal C Herlitz; Denyse Thornley-Brown; Mitchell Rosner; John L Niles
Journal:  Clin J Am Soc Nephrol       Date:  2014-07-17       Impact factor: 8.237

10.  Ruptured Tendons in Anabolic-Androgenic Steroid Users: A Cross-Sectional Cohort Study.

Authors:  Gen Kanayama; James DeLuca; William P Meehan; James I Hudson; Stephanie Isaacs; Aaron Baggish; Rory Weiner; Lyle Micheli; Harrison G Pope
Journal:  Am J Sports Med       Date:  2015-09-11       Impact factor: 6.202

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.